Check out this article on a new drug called Olaparib that is especially promising for the treatment of cancer for BRCA 1 and 2 gene mutation carriers.
It was a small Phase 1 trial so its early in the process for making this drug available to treat cancer (outside of patients being treated in clinical trials). Its taken orally and has few side effects because it only affects cancerous cells, leaving normal cells alone.
Freaking Beautiful!
Monday, June 29, 2009
Subscribe to:
Posts (Atom)
